Non-surgical Treatment of Peri-implant Pockets With H42
Recruiting
Observational Study
Peri-implantitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 25 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 56 (estimated)
- Sponsor
- Bioteck S.p.A. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective, observational study evaluates the efficacy and safety of H42 non-surgical treatment for peri-implant pockets. The trial involves 56 patients, with 28 subjects receiving the H42 treatment and 28 acting as a control group to monitor soft tissue healing and bone level changes.
Clinical outcomes focus on Pocket Probing Depth (PPD) and Silness and Löe Plaque Index (PI) measured at ba…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men or women with age ≥ 25 and ≤ 65 years.
* Subjects affected by peri-implant pockets with probing depth (PD) in the range between 6 to 8 mm.
* Each subject can have from 1 to 5 defects.
* Subjects willing to provide signed informed consent to clinical investigation participa…
Contacts